-
Loading metrics
High RBM3 expression is associated with an improved survival and oxaliplatin response in patients with metastatic colorectal cancer
- Christina Siesing,
- Halfdan Sorbye,
- Anca Dragomir,
- Per Pfeiffer,
- Camilla Qvortrup,
- Fredrik Pontén,
- Karin Jirström,
- Bengt Glimelius,
- Jakob Eberhard
x
- Published: August 11, 2017
- https://doi.org/10.1371/journal.pone.0182512